Company to host public (L)earnings call on August 5th at 8:00 am ET / 6:00 am MT / 1:00 pm BSTSalt Lake City, UT, July 29, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage ...

As AI gets more curious, security gaps widen. Explore the risks of prompt exfiltration and autonomous model behavior.

Given that, it's hardly encouraging that Biodexa has taken a big step forward ahead of Recursion in the development of its ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.